1
|
Graves LE, van Dijk EB, Zhu E, Koyyalamudi S, Wotton T, Sung D, Srinivasan S, Ginn SL, Alexander IE. AAV-delivered hepato-adrenal cooperativity in steroidogenesis: Implications for gene therapy for congenital adrenal hyperplasia. Mol Ther Methods Clin Dev 2024; 32:101232. [PMID: 38558568 PMCID: PMC10979120 DOI: 10.1016/j.omtm.2024.101232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Accepted: 03/08/2024] [Indexed: 04/04/2024]
Abstract
Despite the availability of life-saving corticosteroids for 70 years, treatment for adrenal insufficiency is not able to recapitulate physiological diurnal cortisol secretion and results in numerous complications. Gene therapy is an attractive possibility for monogenic adrenocortical disorders such as congenital adrenal hyperplasia; however, requires further development of gene transfer/editing technologies and knowledge of the target progenitor cell populations. Vectors based on adeno-associated virus are the leading system for direct in vivo gene delivery but have limitations in targeting replicating cell populations such as in the adrenal cortex. One strategy to overcome this technological limitation is to deliver the relevant adrenocortical gene to a currently targetable organ outside of the adrenal cortex. To explore this possibility, we developed a vector encoding human 21-hydroxylase and directed expression to the liver in a mouse model of congenital adrenal hyperplasia. This extra-adrenal expression resulted in reconstitution of the steroidogenic pathway. Aldosterone and renin levels normalized, and corticosterone levels improved sufficiently to reduce adrenal hyperplasia. This strategy could provide an alternative treatment option for monogenic adrenal disorders, particularly for mineralocorticoid defects. These findings also demonstrate, when targeting the adrenal gland, that inadvertent liver transduction should be precluded as it may confound data interpretation.
Collapse
Affiliation(s)
- Lara E. Graves
- Gene Therapy Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia
- Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia
- Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Westmead, NSW 2145, Australia
| | - Eva B. van Dijk
- Gene Therapy Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia
| | - Erhua Zhu
- Gene Therapy Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia
| | - Sundar Koyyalamudi
- Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia
- Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Westmead, NSW 2145, Australia
| | - Tiffany Wotton
- NSW Newborn Screening Program, The Children’s Hospital at Westmead, Westmead, NSW 2145, Australia
| | - Dinah Sung
- NSW Newborn Screening Program, The Children’s Hospital at Westmead, Westmead, NSW 2145, Australia
| | - Shubha Srinivasan
- Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia
- Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Westmead, NSW 2145, Australia
| | - Samantha L. Ginn
- Gene Therapy Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia
| | - Ian E. Alexander
- Gene Therapy Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia
- Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia
| |
Collapse
|
2
|
Kumar BV, Kadiyala P, Ponmalar P, Pauline L, Srinivasan S. Establishment of Age Specific Reference Interval for Aminoacids and Acylcarnitine in Dried Blood Spot by Tandem Mass Spectrometry. Indian J Clin Biochem 2024; 39:233-240. [PMID: 38577134 PMCID: PMC10987407 DOI: 10.1007/s12291-023-01128-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 02/25/2023] [Indexed: 03/12/2023]
Abstract
The Extended Screening for Inborn Errors of Metabolism is done for aminoacidopathies, fatty acid oxidation disorders and organic acid disorders. In a single dried blood spot, the tandem mass spectrometry is capable of measuring multiple analytes like amino acids, acylcarnitines, nucleosides, succinylacetone and lysophosphatidylcholines. This study was proposed to establish age specific reference internal for aminoacids and acylcartinitine in dried blood spot by tandem mass spectrometry. A total of 480 apparently healthy children were enrolled for the study and sub classified into four groups as follows: Group A: 0-1 month, Group B: 1 month-1 year, Group C: 1-5 year and Group D: 5-12 years each having 120 participants. Sample size were calculated as per CLSI approved guidelines. Tables 1 and 2 presents the age-specific percentile distribution of aminoacids and acylcarnitines established from healthy subjects as per rank-based method recommended by the IFCC and CLSI. Tables 3, 4 and 5 presents the cut-off values of primary and secondary marker/ratios for screening of aminoacidopathies, fatty acid oxidation disorders and organic acid disorders respectively. As a general principle, the interpretation of extended newborn screening results should be based on age specific cut-off established by the laboratory for primary analyte concentration and secondary analyte concentration/ ratios. This study was useful in establishing age specific cut-off values for various amino acids and acylcarnitines in South Indian population. [Table: see text] [Table: see text] [Table: see text] [Table: see text] [Table: see text].
Collapse
Affiliation(s)
- B. Vinodh Kumar
- Department of Biochemistry, ICH & HC, Madras Medical College, Chennai, Tamil Nadu India
| | - Pramila Kadiyala
- Department of Biochemistry, ICH & HC, Madras Medical College, Chennai, Tamil Nadu India
| | - P. Ponmalar
- Department of Biochemistry, ICH & HC, Madras Medical College, Chennai, Tamil Nadu India
| | - Leema Pauline
- Department of Neurology, ICH & HC, Madras Medical College, Chennai, India
| | - S. Srinivasan
- Department of Biochemistry, ICH & HC, Madras Medical College, Chennai, Tamil Nadu India
- NHM, ICH & HC, Madras Medical College, Chennai, India
| |
Collapse
|
3
|
Wiegman A, Greber-Platzer S, Ali S, Reijman MD, Brinton EA, Charng MJ, Srinivasan S, Baker-Smith C, Baum S, Brothers JA, Hartz J, Moriarty PM, Mendell J, Bihorel S, Banerjee P, George RT, Hirshberg B, Pordy R. Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia. Circulation 2024; 149:343-353. [PMID: 37860863 PMCID: PMC10814999 DOI: 10.1161/circulationaha.123.065529] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 09/07/2023] [Indexed: 10/21/2023]
Abstract
BACKGROUND Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) levels due to profoundly defective LDL receptor (LDLR) function. Given that severely elevated LDL-C starts in utero, atherosclerosis often presents during childhood or adolescence, creating a largely unmet need for aggressive LDLR-independent lipid-lowering therapies in young patients with HoFH. Here we present the first evaluation of the efficacy and safety of evinacumab, a novel LDLR-independent lipid-lowering therapy, in pediatric patients with HoFH from parts A and B of a 3-part study. METHODS The phase 3, part B, open-label study treated 14 patients 5 to 11 years of age with genetically proven HoFH (true homozygotes and compound heterozygotes) with LDL-C >130 mg/dL, despite optimized lipid-lowering therapy (including LDLR-independent apheresis and lomitapide), with intravenous evinacumab 15 mg/kg every 4 weeks. RESULTS Evinacumab treatment rapidly and durably (through week 24) decreased LDL-C with profound reduction in the first week, with a mean (SE) LDL-C reduction of -48.3% (10.4%) from baseline to week 24. ApoB (mean [SE], -41.3% [9.0%]), non-high-density lipoprotein cholesterol (-48.9% [9.8%]), and total cholesterol (-49.1% [8.1%]) were similarly decreased. Treatment-emergent adverse events were reported in 10 (71.4%) patients; however, only 2 (14.3%) reported events that were considered to be treatment-related (nausea and abdominal pain). One serious treatment-emergent adverse event of tonsillitis occurred (n=1), but this was not considered treatment-related. CONCLUSIONS Evinacumab constitutes a new treatment for pediatric patients with HoFH and inadequately controlled LDL-C despite optimized lipid-lowering therapy, lowering LDL-C levels by nearly half in these extremely high-risk and difficult-to-treat individuals. REGISTRATION URL: https://www.clinicaltrials.gov; Unique identifier: NCT04233918.
Collapse
Affiliation(s)
- Albert Wiegman
- Department of Paediatrics, Amsterdam University Medical Centers, Location University of Amsterdam, The Netherlands (A.W., M.D.R.)
| | - Susanne Greber-Platzer
- Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University of Vienna, Austria (S.G.-P.)
| | - Shazia Ali
- Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)
| | - M. Doortje Reijman
- Department of Paediatrics, Amsterdam University Medical Centers, Location University of Amsterdam, The Netherlands (A.W., M.D.R.)
| | | | - Min-Ji Charng
- Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (M.-J.C.)
| | - Shubha Srinivasan
- Institute of Endocrinology and Diabetes, Children’s Hospital at Westmead, Sydney, Australia (S.S.)
| | - Carissa Baker-Smith
- Pediatric Preventive Cardiology Program, Nemours Cardiac Center, Nemours Children’s Hospital, Wilmington, DE (C.B.-S.)
| | - Seth Baum
- Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)
| | - Julie A. Brothers
- Division of Cardiology, Children’s Hospital of Philadelphia, PA (J.A.B.)
| | - Jacob Hartz
- Department of Cardiology, Boston Children’s Hospital, MA (J.H.)
| | - Patrick M. Moriarty
- Department of Medicine, University of Kansas Medical Center, Kansas City (P.M.M.)
| | - Jeanne Mendell
- Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)
| | | | - Poulabi Banerjee
- Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)
| | - Richard T. George
- Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)
| | - Boaz Hirshberg
- Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)
| | - Robert Pordy
- Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)
| |
Collapse
|
4
|
Rajaram N, Srinivasan S, Verma S. Human navicular bone: a morphometric and morphological evaluation. Surg Radiol Anat 2024; 46:71-79. [PMID: 37968490 DOI: 10.1007/s00276-023-03259-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Accepted: 10/19/2023] [Indexed: 11/17/2023]
Abstract
BACKGROUND The composition of navicular joint complex is crucial to perform surgical interventions for multiple pathological foot aetiologies. The data on human navicular bone and its facets from Indian population remain scarce in literature. AIMS AND OBJECTIVES To evaluate the morphometry and morphology of navicular bone. METHODOLOGY A total of 77 (right: 40; left: 37) dried human navicular bones were used. The collected data were entered and analysed in SPSS software. RESULTS The anteroposterior diameter of navicular bone on right side was 15.19 mm (13.92, 16.77) and on left side was 15.87 mm (13.83, 17.27). The transverse diameter on right and left sides were 34.21 mm (31.74, 36.6) and 33.59 mm (30.23, 35.43), respectively. The vertical diameter measured on the right was 22.31 mm (21.19, 23.94) and on left 22.53 mm (20.8, 24.24). Morphometric evaluation showed no significant difference between right and left navicular bones. The commonest shape for posterior facet was quadrilateral, on the right (62.5%) and left (40.5%). The most common shape of anterior facet for medial cuneiform is quadrilateral, on the right (85%) and left (89.1%). For intermediate cuneiform, triangular facet was common on the right side (72.5%) and on the left (59.5%). The lateral cuneiform facet was bean shaped on right side (72.5%) and quadrilateral on the left side (32.5%). There was a significant difference in shape distribution between right and left (P < 0.05). The median length of the groove for tibialis posterior tendon was 18.01 mm and 16.19 mm on right and left side, respectively. Cuboid facet was observed in 28 (70%) and 26 (65.9%) navicular bones on right and left sides, respectively. CONCLUSION There is no significant difference between right and left bones with regards to morphometric parameters. Morphological evaluation revealed significant difference in the distribution of shape between right and left bones.
Collapse
Affiliation(s)
- Nandini Rajaram
- Department of Anatomy, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605006, India
| | - S Srinivasan
- Department of Anatomy, Saveetha Medical college, Chennai, India
| | - Suman Verma
- Department of Anatomy, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, 605006, India.
| |
Collapse
|
5
|
Ramprasadh SV, Rajakumar S, Srinivasan S, Susha D, Sharma S, Chourasiya R. Computer-Aided Multi-Epitope Based Vaccine Design Against Monkeypox Virus Surface Protein A30L: An Immunoinformatics Approach. Protein J 2023; 42:645-663. [PMID: 37615828 DOI: 10.1007/s10930-023-10150-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/05/2023] [Indexed: 08/25/2023]
Abstract
Monkeypox, a viral zoonotic disease resembling smallpox, has emerged as a significant national epidemic primarily in Africa. Nevertheless, the recent global dissemination of this pathogen has engendered apprehension regarding its capacity to metamorphose into a sweeping pandemic. To effectively combat this menace, a multi-epitope vaccine has been meticulously engineered with the specific aim of targeting the cell envelope protein of Monkeypox virus (MPXV), thereby stimulating a potent immunological response while mitigating untoward effects. This new vaccine uses T-cell and B-cell epitopes from a highly antigenic, non-allergenic, non-toxic, conserved, and non-homologous A30L protein to provide protection against the virus. In order to ascertain the vaccine design with the utmost efficacy, protein-protein docking methodologies were employed to anticipate the intricate interactions with Toll-like receptors (TLR) 2, 3, 4, 6, and 8. This meticulous approach led the researchers to discern an optimal vaccine architecture, bolstered by affirmative prognostications derived from both molecular dynamics (MD) simulations and immune simulations. The current research findings indicate that the peptides ATHAAFEYSK, FFIVVATAAV, and MNSLSIFFV exhibited antigenic properties and were determined to be non-allergenic and non-toxic. Through the utilization of codon optimization and in-silico cloning techniques, our investigation revealed that the prospective vaccine exhibited a remarkable expression level within Escherichia coli. Moreover, upon conducting immune simulations, we observed the induction of a robust immune response characterized by elevated levels of both B-cell and T-cell mediated immunity. Moreover, as the initial prediction with in-silico techniques has yielded promising results these epitope-based vaccines can be recommended to in vitro and in silico studies to validate their immunogenic properties.
Collapse
Affiliation(s)
- S V Ramprasadh
- Department of Bioinformatics, BioNome, Bangalore, 560043, India
| | | | - S Srinivasan
- Department of Bioinformatics, BioNome, Bangalore, 560043, India
| | - D Susha
- Department of Bioinformatics, BioNome, Bangalore, 560043, India
| | - Sameer Sharma
- Department of Bioinformatics, BioNome, Bangalore, 560043, India.
| | | |
Collapse
|
6
|
Page MM, Hardikar W, Alex G, Bates S, Srinivasan S, Stormon M, Hall K, Evans HM, Johnston P, Chen J, Wigg A, John L, Ekinci EI, O'Brien RC, Jones R, Watts GF. Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand. Atherosclerosis 2023; 387:117305. [PMID: 37863699 DOI: 10.1016/j.atherosclerosis.2023.117305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Revised: 09/14/2023] [Accepted: 09/20/2023] [Indexed: 10/22/2023]
Abstract
BACKGROUND AND AIMS Homozygous familial hypercholesterolaemia (FH) causes severe cardiovascular disease from childhood. Conventional drug therapy is usually ineffective; lipoprotein apheresis (LA) is often required. Liver transplantation (LT) can correct the metabolic defect but is considered a treatment of last resort. Newer drugs including lomitapide and evinacumab might reduce the need for apheresis and LT. We sought to determine the long-term outcomes following LT in Australia and New Zealand. METHODS We analysed demographic, biochemical and clinical data from all patients in Australia and New Zealand who have received LT for homozygous FH, identified from the Australia and New Zealand Liver and Intestinal Transplant Registry. RESULTS Nine patients (five female; one deceased; seven aged between 3 and 6 years at the time of LT and two aged 22 and 26 years) were identified. Mean follow-up was 14.1 years (range 4-27). Baseline LDL-cholesterol off all treatment was 23 ± 4.1 mmol/L. Mean LDL-cholesterol on medical therapy (including maximal statin therapy in all patients, ezetimibe in three and LA in five) was 11 ± 5.7 mmol/L (p < 0.001). After LT, mean LDL-cholesterol was 2.6 ± 0.9 mmol/L (p = 0.004) with three patients remaining on statin therapy and none on LA. One patient died from acute myocardial infarction (AMI) three years after LT. Two patients required aortic valve replacement, more than 10 years after LT. The remaining six patients were asymptomatic after eight to 21 years of follow-up. No significant adverse events associated with immunosuppression were reported. CONCLUSIONS LT for homozygous FH was highly effective in achieving substantial long-term reduction in LDL-cholesterol concentrations in all nine patients. LT remains an option for severe cases of homozygous FH where drug therapy combined with apheresis is ineffective or unfeasible.
Collapse
Affiliation(s)
- Michael M Page
- Medical School, The University of Western Australia, Perth, Australia; Western Diagnostic Pathology, Perth, Australia
| | - Winita Hardikar
- Gastroenterology and Clinical Nutrition, The Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia
| | - George Alex
- Gastroenterology and Clinical Nutrition, The Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia
| | - Sue Bates
- Gastroenterology and Clinical Nutrition, The Royal Children's Hospital Melbourne, Melbourne, Australia
| | - Shubha Srinivasan
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, Australia
| | - Michael Stormon
- Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Gastroenterology and Hepatology, The Children's Hospital at Westmead, Sydney, Australia
| | - Kat Hall
- Hepatobiliary and Liver Transplant Surgery Unit, Austin Health, Melbourne, Australia
| | - Helen M Evans
- Paediatric Gastroenterology and Hepatology, Starship Child Health, Auckland, New Zealand; Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
| | - Peter Johnston
- New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand
| | - John Chen
- South Australia Liver Transplant Unit, Flinders Medical Centre, Adelaide, Australia; College of Medicine and Public Health, Flinders University, Adelaide, Australia
| | - Alan Wigg
- South Australia Liver Transplant Unit, Flinders Medical Centre, Adelaide, Australia; College of Medicine and Public Health, Flinders University, Adelaide, Australia
| | - Libby John
- South Australia Liver Transplant Unit, Flinders Medical Centre, Adelaide, Australia
| | - Elif I Ekinci
- Department of Endocrinology, Austin Health, Melbourne, Australia; The Australian Centre for Accelerating Diabetes Innovation, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia; Department of Medicine, Austin Health, Melbourne Medical School, The University of Melbourne, Melbourne, Australia
| | - Richard C O'Brien
- Department of Endocrinology, Austin Health, Melbourne, Australia; Department of Medicine, Austin Health, Melbourne Medical School, The University of Melbourne, Melbourne, Australia
| | - Robert Jones
- Hepatobiliary and Liver Transplant Surgery Unit, Austin Health, Melbourne, Australia; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia
| | - Gerald F Watts
- Medical School, The University of Western Australia, Perth, Australia; Department of Cardiovascular Medicine, Royal Perth Hospital, Perth, Australia.
| |
Collapse
|
7
|
Ludwig K, Lai F, Wiley V, Ravine A, Srinivasan S. Genotyping in patients with congenital adrenal hyperplasia by sequencing of newborn bloodspot samples. J Pediatr Endocrinol Metab 2023; 36:966-973. [PMID: 37728028 DOI: 10.1515/jpem-2023-0044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2023] [Accepted: 09/01/2023] [Indexed: 09/21/2023]
Abstract
OBJECTIVES Genotype-phenotype correlation in congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency ranges from 45 to 97 %. We performed massively parallel sequencing of CYP21A2 on stored newborn bloodspot samples to catalogue the genotypes present in our patients with CAH and enable genotype-phenotype comparison. METHODS Participants ≤15 years old with clinically diagnosed CAH were recruited from The Sydney Children's Hospitals Network. Phenotype was classified from clinical and biochemical details in the medical record as salt wasting (SW), simple virilising (SV), non-classic (NC) or an intermediate phenotype (SW/SV; SV/NC). Amplicon-based sequencing for CYP21A2 was performed on stored newborn bloodspot samples by the New South Wales Newborn Bloodspot Screening Laboratory on MiSeq™Dx (Illumina, California). Available genetic test results were also obtained from the medical records. RESULTS Samples from 67 participants (43 % female, age 0.3-15 years) were sequenced, including 9 sibships. SW phenotype was present in 33/67 participants (49 %), SV in 9 (13 %) and NC in 16 (24 %). Intermediate phenotypes included SW/SV in seven participants (10 %) and SV/NC in two (3 %). Variants were identified in 90/116 alleles (78 %). A complete genotype was available in 47/67 participants (70 %). The most common genotype was homozygous c.293-13A/C>G (I2G) in 7/47 participants (15 %). Genotype correlated with the most commonly reported phenotype in 36/44 cases (82 %). Correlation was higher in SW and NC phenotypes. CONCLUSIONS This study uses genetic testing of newborn bloodspots to identify and characterise the genotypes present in an ethnically diverse Australian population with CAH. It further strengthens our knowledge of genotype-phenotype correlations in CAH.
Collapse
Affiliation(s)
- Karissa Ludwig
- Department of Endocrinology, Queensland Children's Hospital, South Brisbane, QLD, Australia
| | - Fei Lai
- Faculty of Child and Adolescent Health, The University of Sydney, Camperdown, NSW, Australia
- NSW Newborn Screening Programme, Westmead, NSW, Australia
| | - Veronica Wiley
- Faculty of Child and Adolescent Health, The University of Sydney, Camperdown, NSW, Australia
- NSW Newborn Screening Programme, Westmead, NSW, Australia
| | - Anja Ravine
- Faculty of Child and Adolescent Health, The University of Sydney, Camperdown, NSW, Australia
- Molecular Genetics, Western Sydney Genetics Program, Westmead, NSW, Australia
| | - Shubha Srinivasan
- Faculty of Child and Adolescent Health, The University of Sydney, Camperdown, NSW, Australia
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Westmead, NSW, Australia
| |
Collapse
|
8
|
Ramya RK, Theraka K, Ramprasadh SV, Bharathi SV, Srinivasan S, Jacob S, Kuila A. Pragmatic Treatment Strategies for Polyaromatic Hydrocarbon Remediation and Anti-biofouling from Surfaces Using Nano-enzymes: a Review. Appl Biochem Biotechnol 2023; 195:5479-5496. [PMID: 35138553 DOI: 10.1007/s12010-022-03848-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/31/2022] [Indexed: 11/02/2022]
Abstract
In this review, two important environmental pollutants have been considered for its potential remediation using microbial-derived nano-enzymes. Firstly, polyaromatic hydrocarbons (PAHs) are one of the major industrial contaminants in the environment due to their ubiquitous occurrence, toxicity, and proclivity for bioaccumulation. Secondly, biofouling due to biofilm-forming organisms that impact tremendous economic and environmental consequences in many industries, especially marine vessels where it causes an increase in hydrodynamic drag, which results in a loss of ship speed at constant power or a power increase to maintain the same speed with higher fuel consumption and emissions into the atmosphere, particularly Green House Gases (GHGs). Among the remediation strategies, biological routes are found to be promising, efficient, and sustainable. Natural ligninolytic enzymes such as MnP, LiP, laccase, peroxidases, and polysaccharide and protein degradative enzymes are found to be highly efficient for PAH degradation and antifouling respectively. However, large-scale usage of these enzymes is difficult due to various reasons like their poor stability, adaptation, and high-cost production of these enzymes. In recent years, the use of nanoparticles, particularly nano-enzymes, is found to be an innovative and synergistic approach to detoxify contaminated areas with concomitant maintenance of enzyme stability.
Collapse
Affiliation(s)
- Rajesh Khanna Ramya
- Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu Dist, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India
| | - Karthikeyan Theraka
- Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu Dist, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India
| | - Swaminathan Viji Ramprasadh
- Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu Dist, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India
| | - Sundaramoorthy Vijaya Bharathi
- Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu Dist, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India
| | - S Srinivasan
- Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu Dist, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India
| | - Samuel Jacob
- Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu Dist, SRM Nagar, Kattankulathur, 603203, Tamil Nadu, India.
| | - Arindam Kuila
- Department of Bioscience and Biotechnology, Banasthali Vidyapith, Banasthali, Rajasthan, 304022, India.
| |
Collapse
|
9
|
Graves LE, Horton A, Alexander IE, Srinivasan S. Gene Therapy for Paediatric Homozygous Familial Hypercholesterolaemia. Heart Lung Circ 2023; 32:769-779. [PMID: 37012174 DOI: 10.1016/j.hlc.2023.01.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2022] [Revised: 11/26/2022] [Accepted: 01/04/2023] [Indexed: 04/03/2023]
Abstract
The clinical outcome for children and adolescents with homozygous familial hypercholesterolaemia (HoFH) can be devastating, and treatment options are limited in the presence of a null variant. In HoFH, atherosclerotic risk accumulates from birth. Gene therapy is an appealing treatment option as restoration of low-density lipoprotein receptor (LDLR) gene function could provide a cure for HoFH. A clinical trial using a recombinant adeno-associated vector (rAAV) to deliver LDLR DNA to adult patients with HoFH was recently completed; results have not yet been reported. However, this treatment strategy may face challenges when translating to the paediatric population. The paediatric liver undergoes substantial growth which is significant as rAAV vector DNA persists primarily as episomes (extra-chromosomal DNA) and are not replicated during cell division. Therefore, rAAV-based gene addition treatment administered in childhood would likely only have a transient effect. With over 2,000 unique variants in LDLR, a goal of genomic editing-based therapy development would be to treat most (if not all) mutations with a single set of reagents. For a robust, durable effect, LDLR must be repaired in the genome of hepatocytes, which could be achieved using genomic editing technology such as clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 and a DNA repair strategy such as homology-independent targeted integration. This review discusses this issue in the context of the paediatric patient group with severe compound heterozygous or homozygous null variants which are associated with aggressive early-onset atherosclerosis and myocardial infarction, together with the important pre-clinical studies that use genomic editing strategies to treat HoFH in place of apheresis and liver transplantation.
Collapse
Affiliation(s)
- Lara E Graves
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, NSW, Australia; Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, NSW, Australia; Gene Therapy Research Unit, Children's Medical Research Institute, Sydney, NSW, Australia.
| | - Ari Horton
- Monash Heart and Monash Children's Hospital, Monash Health, Melbourne, Vic, Australia; Monash Cardiovascular Research Centre, Victorian Heart Institute, Melbourne, Vic, Australia; Monash Genetics, Monash Health, Melbourne, Vic, Australia; Department of Genomic Medicine, The Royal Melbourne Hospital, Parkville, Vic, Australia; Department of Paediatrics, Monash University Clayton, Vic, Australia
| | - Ian E Alexander
- Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, NSW, Australia; Gene Therapy Research Unit, Children's Medical Research Institute, Sydney, NSW, Australia
| | - Shubha Srinivasan
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, NSW, Australia; Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, NSW, Australia
| |
Collapse
|
10
|
Srinivasan S. The vaccine mandates judgment: Some reflections. Indian J Med Ethics 2023; VIII:134-140. [PMID: 36880474 DOI: 10.20529/ijme.2022.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
This paper scrutinises the Supreme Court Judgment of May 2, 2022, in a vaccine mandate-related petition. The Hon'ble Court's Order reasserts the primacy of right to privacy and Articles 14 and 21 of the Constitution of India. However, in the interest of protection of communitarian health, the Court felt that the Government is entitled to regulate issues of public health concern by imposing certain limitations on individual rights, which are open to scrutiny by constitutional Courts. However, such mandatory vaccination directives with preconditions cannot invade an individual's right to personal autonomy and right to access means of livelihood, and must meet the threefold criteria laid down in K.S.Puttaswamy, a landmark judgment of 2017. This paper examines the validity of the arguments adopted in the Order and suggests certain infirmities therein. Nevertheless, the Order is a balancing act, and worth celebrating. The paper concludes, as a cup that is "a quarter full", as a victory for human rights and as a safeguard against unreasonableness and arbitrariness in medico-scientific decision-making that takes the citizen's compliance and consent for granted. If the State runs amok by way of mandatory health directives, this Order may come to the rescue of the hapless citizen.
Collapse
Affiliation(s)
- S Srinivasan
- All-India Drug Action Network (AIDAN); and LOCOST Vadodara, Gujarat, INDIA
| |
Collapse
|
11
|
Mahawar B, Kannan A, Mahawar V, Srinivasan S. Intrathecal pain pumps in pain relief. Clin Radiol 2023; 78:240-244. [PMID: 36841671 DOI: 10.1016/j.crad.2023.02.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2023] [Revised: 02/08/2023] [Accepted: 02/09/2023] [Indexed: 02/18/2023]
Abstract
Chronic pain is a significant global health issue, described as a bio-psychosocial phenomenon that hampers the integration of body, mind, and social functions. To relieve chronic intractable pain, intrathecal drug-delivery devices (IDDDs) are the last resort after conventional treatment options have been exhausted. This article outlines the indications, pharmacological agents, types, techniques, preparation of the patient, and complications of IDDDs for the management of challenging chronic pain (non-neoplastic and cancer-related pain) conditions in patients who have not responded well to a commonly used conventional line of treatment.
Collapse
Affiliation(s)
- B Mahawar
- Interventional Pain and Palliative Care Department, Ramkrishna CARE Hospital, Raipur, 492001, India
| | - A Kannan
- Department of Anaesthesiology, Singapore General Hospital, Singapore, 169608, Republic of Singapore
| | - V Mahawar
- Radiodiagnosis and Intervention Radiology Department, Ramkrishna CARE Hospital, Raipur, 492001, India
| | - S Srinivasan
- Department of Diagnostic Radiology, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore, 768828, Republic of Singapore.
| |
Collapse
|
12
|
Tombal B, Saad F, Fizazi K, Sternberg C, Crawford E, Gratzke C, Grabbert M, Vilaseca A, Shore N, Kopyltsov E, Bögemann M, Kapur S, Srinivasan S, Verholen F, Kuss I, Joensuu H, Smith M, Hussain M. Efficacy and safety of darolutamide (DARO) in combination with androgen-deprivation therapy (ADT) and docetaxel (DOC) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC) by metastatic burden: Subgroup analyses of ARASENS. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01221-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
13
|
Christy Evangeline N, Srinivasan S, Suresh E. Application of non-contact thermography as a screening modality for Diabetic Foot Syndrome – A real time cross sectional research outcome. Biomed Signal Process Control 2023. [DOI: 10.1016/j.bspc.2022.104054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
14
|
Evangeline N C, Srinivasan S, Suresh E. Development of AI classification model for angiosome-wise interpretive substantiation of plantar feet thermal asymmetry in type 2 diabetic subjects using infrared thermograms. J Therm Biol 2022; 110:103370. [DOI: 10.1016/j.jtherbio.2022.103370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 10/01/2022] [Accepted: 10/06/2022] [Indexed: 12/03/2022]
|
15
|
Srinivasan S, Hajam TA, Sathish S, Grewal RK. Synthesis, quantum mechanical calculations, molecular docking, Hirshfeld surface analysis and ADMET estimation studies of (E)-3-(anthracene-10-yl)-1-(napthalen-1-yl)prop-2-en-1-one. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.133748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
16
|
Saravanan A, Kumar PS, Nhung TC, Ramesh B, Srinivasan S, Rangasamy G. A review on biological methodologies in municipal solid waste management and landfilling: Resource and energy recovery. Chemosphere 2022; 309:136630. [PMID: 36181855 DOI: 10.1016/j.chemosphere.2022.136630] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/24/2022] [Revised: 08/24/2022] [Accepted: 09/25/2022] [Indexed: 06/16/2023]
Abstract
Rapid industrialization and urbanization growth combined with increased population has aggravated the issue of municipal solid waste generation. MSW has been accounted for contributing tremendously to the improvement of sustainable sources and safe environment. Biological processing of MSW followed by biogas and biomethane generation is one of the innumerable sustainable energy source choices. In the treatment of MSW, biological treatment has some attractive benefits such as reduced volume in the waste material, adjustment of the waste, economic aspects, obliteration of microorganisms in the waste material, and creation of biogas for energy use. In the anaerobic process the utilizable product is energy recovery. The current review discusses about the system for approaching conversion of MSW to energy and waste derived circular bioeconomy to address the zero waste society and sustainable development goals. Biological treatment process adopted with aerobic and anaerobic processes. In the aerobic process the utilizable product is compost. These techniques are used to convert MSW into a reasonable hotspot for resource and energy recovery that produces biogas, biofuel and bioelectricity and different results in without risk and harmless to the ecosystem. This review examines the suitability of biological treatment technologies for energy production, giving modern data about it. It likewise covers difficulties and points of view in this field of exploration.
Collapse
Affiliation(s)
- A Saravanan
- Department of Sustainable Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - Ponnusamy Senthil Kumar
- Green Technology and Sustainable Development in Construction Research Group, School of Engineering and Technology, Van Lang University, Ho Chi Minh City, Vietnam.
| | - Tran Cam Nhung
- Faculty of Safety Engineering, School of Engineering and Technology, Van Lang University, Ho Chi Minh City, Vietnam
| | - B Ramesh
- Department of Sustainable Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - S Srinivasan
- Department of Sustainable Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - Gayathri Rangasamy
- University Centre for Research and Development & Department of Civil Engineering, Chandigarh University, Gharuan, Mohali, Punjab, 140413, India
| |
Collapse
|
17
|
Fizazi K, Smith M, Hussain M, Saad F, Sternberg C, Crawford E, Aragon-Ching J, Thiele S, Kapur S, Mohamed A, Srinivasan S, Li R, Kuss I, Joensuu H, Tombal B. 1360MO Quality of life and patient-relevant endpoints with darolutamide in the phase III ARASENS study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
18
|
Chawla S, Batty K, Alečković M, Bhadri V, Bui N, Guminski A, Mejía Oneto J, Srinivasan S, Strauss J, Subbiah V, Weiss M, Wilson R, Yee N, Zakharian M, Kwatra V. 1499P Phase I clinical & immunologic data of SQ3370 in advanced solid tumors. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
19
|
Umapathi M, Kalarani MK, Srinivasan S, Kalaiselvi P. Alleviation of cadmium phytotoxicity through melatonin modulated physiological functions, antioxidants, and metabolites in tomato (Solanum lycopersicum L.). Biometals 2022; 35:1113-1132. [PMID: 35951199 DOI: 10.1007/s10534-022-00428-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Accepted: 07/25/2022] [Indexed: 11/26/2022]
Abstract
The rising concentration of cadmium (Cd) builds a harmful effect on human and plant health associated with food chain contagion. Melatonin (MT) is an indole compound. Hence, the experiment was conducted to understand the physiological and biochemical mechanism of Cd detoxification by exogenous MT in tomato. Pots were filled with 30 ppm of Cd spiked soil and different concentration of exogenous MT was given to the plants through seed treatment (250 ppm), foliar spray viz., 25, 50, and 100 ppm, and both, whereas the foliar spray was given at 30 days after transplanting (DAT) and 46 DAT. When the plants are exposed to Cd stress, it reduces the gas exchange characters. The results revealed that foliar spray of 25 ppm of exogenous MT recorded the highest photosynthetic rate, stomatal conductance, and osmotic potential. MT had a direct interaction with reactive oxygen species scavenging by elevating endogenous antioxidant enzymes as well as the metabolites in plants. The contribution of MT foliar spray of 25 ppm at 30 and 46 DAT can mitigate Cd stress and it has potential implications for ensuring food safety and food security in marginal agriculture.
Collapse
Affiliation(s)
- M Umapathi
- Department of Crop Physiology, Tamil Nadu Agricultural University, Coimbatore, India.
| | - M K Kalarani
- Department of Crop Physiology, Tamil Nadu Agricultural University, Coimbatore, India
| | - S Srinivasan
- Regional Research Station, Tamil Nadu Agricultural University, Aruppukottai, India
| | - P Kalaiselvi
- Department of Environmental Sciences, Tamil Nadu Agricultural University, Coimbatore, India
| |
Collapse
|
20
|
Wei KX, Magesan E, Lauer I, Srinivasan S, Bogorin DF, Carnevale S, Keefe GA, Kim Y, Klaus D, Landers W, Sundaresan N, Wang C, Zhang EJ, Steffen M, Dial OE, McKay DC, Kandala A. Hamiltonian Engineering with Multicolor Drives for Fast Entangling Gates and Quantum Crosstalk Cancellation. Phys Rev Lett 2022; 129:060501. [PMID: 36018659 DOI: 10.1103/physrevlett.129.060501] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Accepted: 06/14/2022] [Indexed: 06/15/2023]
Abstract
Quantum computers built with superconducting artificial atoms already stretch the limits of their classical counterparts. While the lowest energy states of these artificial atoms serve as the qubit basis, the higher levels are responsible for both a host of attractive gate schemes as well as generating undesired interactions. In particular, when coupling these atoms to generate entanglement, the higher levels cause shifts in the computational levels that lead to unwanted ZZ quantum crosstalk. Here, we present a novel technique to manipulate the energy levels and mitigate this crosstalk with simultaneous off-resonant drives on coupled qubits. This breaks a fundamental deadlock between qubit-qubit coupling and crosstalk. In a fixed-frequency transmon architecture with strong coupling and crosstalk cancellation, additional cross-resonance drives enable a 90 ns CNOT with a gate error of (0.19±0.02)%, while a second set of off-resonant drives enables a novel CZ gate. Furthermore, we show a definitive improvement in circuit performance with crosstalk cancellation over seven qubits, demonstrating the scalability of the technique. This Letter paves the way for superconducting hardware with faster gates and greatly improved multiqubit circuit fidelities.
Collapse
Affiliation(s)
- K X Wei
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - E Magesan
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - I Lauer
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - S Srinivasan
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - D F Bogorin
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - S Carnevale
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - G A Keefe
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - Y Kim
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - D Klaus
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - W Landers
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - N Sundaresan
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - C Wang
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - E J Zhang
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - M Steffen
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - O E Dial
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - D C McKay
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - A Kandala
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| |
Collapse
|
21
|
Horton AE, Martin AC, Srinivasan S, Justo RN, Poplawski NK, Sullivan D, Brett T, Chow CK, Nicholls SJ, Pang J, Watts GF. Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician. J Paediatr Child Health 2022; 58:1297-1312. [PMID: 35837752 PMCID: PMC9545564 DOI: 10.1111/jpc.16096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2022] [Revised: 05/17/2022] [Accepted: 05/28/2022] [Indexed: 11/28/2022]
Abstract
Familial hypercholesterolaemia (FH) is a highly penetrant monogenic disorder present from birth that markedly elevates plasma low-density lipoprotein (LDL)-cholesterol (LDL-C) concentration and, if untreated, leads to premature atherosclerosis and coronary artery disease (CAD). At a prevalence of 1:250 individuals, with over 90% undiagnosed, recent estimates suggest that there are approximately 22 000 children and adolescents with FH in Australia and New Zealand. However, the overwhelming majority remain undetected and inadequately treated until adulthood or after their first cardiac event. The guidance in this paper aims to increase awareness about paediatric FH and provide practical advice for the diagnosis and management of FH in children and adolescents. Recommendations are given on the detection, diagnosis, assessment and management of FH in children and adolescents. Recommendations are also made on genetic testing, including counselling and the potential for universal screening programmes. Practical guidance on management includes treatment of non-cholesterol risk factors, and safe and appropriate use of LDL-C lowering therapies, including statins, ezetimibe, PCSK9 inhibitors and lipoprotein apheresis. Models of care for FH need to be adapted to local and regional health care needs and available resources. Targeting the detection of FH as a priority in children and young adults has the potential to alter the natural history of atherosclerotic cardiovascular disease and recognise the promise of early detection for improving long-term health outcomes. A comprehensive implementation strategy, informed by further research, including assessments of cost-benefit, will be required to ensure that this new guidance benefits all families with or at risk of FH.
Collapse
Affiliation(s)
- Ari E Horton
- Monash Heart and Monash Children's HospitalMonash HealthMelbourneVictoriaAustralia,Monash Cardiovascular Research Centre, Victorian Heart InstituteMonash UniversityMelbourneVictoriaAustralia,Department of PaediatricsMonash UniversityMelbourneVictoriaAustralia
| | - Andrew C Martin
- Department General PaediatricsPerth Children's HospitalPerthWestern AustraliaAustralia,Division of Paediatrics, Faculty of Health and Medical SciencesUniversity of Western AustraliaPerthWestern AustraliaAustralia
| | - Shubha Srinivasan
- Institute of Endocrinology and DiabetesThe Children's Hospital at WestmeadSydneyNew South WalesAustralia,Discipline of Child and Adolescent Health, Faculty of Medicine and HealthUniversity of SydneySydneyNew South WalesAustralia
| | - Robert N Justo
- Department of Paediatric CardiologyQueensland Children's HospitalBrisbaneQueenslandAustralia,School of MedicineUniversity of QueenslandBrisbaneQueenslandAustralia
| | - Nicola K Poplawski
- Adult Genetics UnitRoyal Adelaide HospitalAdelaideSouth AustraliaAustralia,Adelaide Medical SchoolUniversity of AdelaideAdelaideSouth AustraliaAustralia
| | - David Sullivan
- Department of Chemical PathologyRoyal Prince Alfred HospitalSydneyNew South WalesAustralia,Sydney Medical School, Faculty of Medicine and HealthUniversity of SydneySydneyNew South WalesAustralia
| | - Tom Brett
- General Practice and Primary Health Care Research, School of MedicineUniversity of Notre Dame AustraliaFremantleWestern AustraliaAustralia
| | - Clara K Chow
- Westmead Applied Research CentreThe University of SydneySydneyNew South WalesAustralia,Department of CardiologyWestmead HospitalSydneyNew South WalesAustralia,Cardiovascular DivisionGeorge Institute for Global HealthSydneyNew South WalesAustralia
| | - Stephen J Nicholls
- Monash Heart and Monash Children's HospitalMonash HealthMelbourneVictoriaAustralia,Monash Cardiovascular Research Centre, Victorian Heart InstituteMonash UniversityMelbourneVictoriaAustralia
| | - Jing Pang
- School of Medicine, Faculty of Health and Medical SciencesUniversity of Western AustraliaPerthWestern AustraliaAustralia
| | - Gerald F Watts
- School of Medicine, Faculty of Health and Medical SciencesUniversity of Western AustraliaPerthWestern AustraliaAustralia,Lipid Disorders Clinic, Cardiometabolic Service, Department of CardiologyRoyal Perth HospitalPerthWestern AustraliaAustralia,Lipid Disorders Clinic, Cardiometabolic Service, Department of Internal MedicineRoyal Perth HospitalPerthWestern AustraliaAustralia
| | | |
Collapse
|
22
|
Saravanan A, Kumar PS, Ramesh B, Srinivasan S. Removal of toxic heavy metals using genetically engineered microbes: Molecular tools, risk assessment and management strategies. Chemosphere 2022; 298:134341. [PMID: 35307383 DOI: 10.1016/j.chemosphere.2022.134341] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/03/2022] [Revised: 03/03/2022] [Accepted: 03/14/2022] [Indexed: 06/14/2023]
Abstract
The direct release of industrial effluent into the water and other anthropogenic activities causes water pollution. Heavy metal ions are the primary contaminant in the industrial effluents which are exceptionally toxic at low concentrations, terribly disturb the endurance equilibrium of activities in the eco-system and be remarkably hazardous to human health. Different conventional treatment methodologies were utilized for the removal of toxic pollutants from the contaminated water which has several drawbacks such as cost-ineffective and lower efficiency. Recently, genetically modified micro-organisms (GMMs) stand-out for the removal of toxic heavy metals are viewed as an economically plausible and environmentally safe technique. GMMs are microorganisms whose genetic material has been changed utilizing genetic engineering techniques that exhibit enhanced removal efficiency in comparison with the other treatment methodologies. The present review comments the GMMs such as bacteria, algae and fungi and their potential for the removal of toxic heavy metals. This review provides current aspects of different advanced molecular tools which have been used to manipulate micro-organisms through genetic expression for the breakdown of metal compounds in polluted areas. The strategies, major limitations and challenges for genetic engineering of micro-organisms have been reviewed. The current review investigates the approaches working on utilizing genetically modified micro-organisms and effective removal techniques.
Collapse
Affiliation(s)
- A Saravanan
- Department of Sustainable Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - P Senthil Kumar
- Department of Chemical Engineering, Sri Sivasubramaniya Nadar College of Engineering, Chennai, 603110, India; Centre of Excellence in Water Research (CEWAR), Sri Sivasubramaniya Nadar College of Engineering, Chennai, 603110, India.
| | - B Ramesh
- Department of Sustainable Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - S Srinivasan
- Department of Sustainable Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| |
Collapse
|
23
|
Saravanan A, Kumar PS, Srinivasan S, Jeevanantham S, Vishnu M, Amith KV, Sruthi R, Saravanan R, Vo DVN. Insights on synthesis and applications of graphene-based materials in wastewater treatment: A review. Chemosphere 2022; 298:134284. [PMID: 35283157 DOI: 10.1016/j.chemosphere.2022.134284] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/08/2022] [Revised: 02/21/2022] [Accepted: 03/07/2022] [Indexed: 06/14/2023]
Abstract
Graphene has excellent unique thermal, chemical, optical, and mechanical properties such as high thermal conductivity, high chemical stability, optical transmittance, high current density, higher surface area, etc. Due to their outstanding properties, the attention towards graphene-based materials and their derivatives in wastewater treatment has been increased in recent times. Different graphene-based materials such as graphene oxides, graphene quantum dots, graphene nanoplatelets, graphene nanoribbons and other graphene-based nanocomposites are synthesized through chemical vapor deposition, mechanical and electrochemical exfoliation of graphite. In this review, the specifics about the graphenes and their derivatives, the synthesis strategy of graphene-based materials are described. This review critically explained the applications of graphene-based materials in wastewater treatment. Graphene-based materials were utilized as adsorbents, electrodes, and photocatalysts for the efficient removal of toxic pollutants such as heavy metals, dyes, pharmaceutics, antibiotics, phenols, polycyclic aromatic hydrocarbons have been highlighted and discussed. Herein, the potential scope of graphene-based material in the field of wastewater treatment is critically reviewed. In addition, a brief perspective on future research directions and difficulties in the synthesis of graphene-based material are summarized.
Collapse
Affiliation(s)
- A Saravanan
- Department of Energy and Environmental Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - P Senthil Kumar
- Department of Chemical Engineering, Sri Sivasubramaniya Nadar College of Engineering, Chennai, 603110, India; Centre of Excellence in Water Research (CEWAR), Sri Sivasubramaniya Nadar College of Engineering, Chennai, 603110, India.
| | - S Srinivasan
- Department of Biomedical Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - S Jeevanantham
- Department of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamilnadu, 602105, India
| | - M Vishnu
- Department of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamilnadu, 602105, India
| | - K Vishal Amith
- Department of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamilnadu, 602105, India
| | - R Sruthi
- Department of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamilnadu, 602105, India
| | - R Saravanan
- Department of Mechanical Engineering, Universidad de Tarapacá, Arica, Chile
| | - Dai-Viet N Vo
- Institute of Environmental Sciences, Nguyen Tat Thanh University, Ho Chi Minh City, Viet Nam
| |
Collapse
|
24
|
Affiliation(s)
- Jayashree Mondkar
- Department of Neonatology, Lokmanya Tilak Municipal Medical College & General Hospital, Sion, Mumbai, Maharashtra, India
| | - S. Srinivasan
- Department of Pediatrics, Mehta Multispeciality Hospital, Chennai, Tamil Nadu, India
| |
Collapse
|
25
|
Alagoz O, Ajani J, Srinivasan S, Kim I, Singh P, Xiao H, Kurt M. P-56 Estimating endpoint correlation between surrogate measures and overall survival using reconstructed survival data: Case studies from adjuvant and metastatic gastric cancer trials. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
26
|
Mummudi N, Jiwnani S, Niyogi D, Srinivasan S, Ghosh-Laskar S, Tibdewal A, Rane P, Karimundackal G, Pramesh CS, Agarwal JP. Salvage radiotherapy for postoperative locoregional failure in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2022; 35:6257764. [PMID: 33912933 DOI: 10.1093/dote/doab020] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2020] [Revised: 02/02/2020] [Indexed: 12/11/2022]
Abstract
Locoregional recurrences following surgery for esophageal cancers represent a significant clinical problem with no standard recommendations for management. We conducted this systematic review and meta-analysis with the objective of studying safety and efficacy of salvage radiotherapy in this setting. All prospective and retrospective cohort studies, which studied patients who developed locoregional recurrence following initial radical surgery for esophageal cancer and subsequently received salvage radiation therapy (RT)/chemoradiation with all relevant information regarding survival outcome and toxicity available, were included. The quality of eligible individual studies was assessed using the Newcastle-Ottawa Scale score for risk of bias. R package MetaSurv was used to obtain a summary survival curve from survival probabilities and numbers of at-risk patients collected at various time points and to test the overall heterogeneity using the I2 statistic. Thirty studies (27 retrospective, 3 prospective) published from 1995 to 2020 with 1553 patients were included. The median interval between surgery and disease recurrence was 12.5 months. The median radiation dose used was 60 Gy and 57% received concurrent chemotherapy. The overall incidence of acute grade 3/4 mucositis and dermatitis were 8 and 4%, respectively; grade 3/4 acute pneumonitis was reported in 5%. The overall median follow-up of all studies included was 27 months. The 1-, 2- and 3-year overall survival (OS) probabilities were 67.9, 35.9 and 30.6%, respectively. Factors which predicted better survival on multivariate analysis were good PS, lower group stage, node negativity at index surgery, longer disease-free interval, nodal recurrence (as compared to anastomotic site recurrence), smaller disease volume, single site of recurrence, RT dose >50 Gy, conformal RT, use of concomitant chemotherapy and good radiological response after radiotherapy. Salvage radiotherapy with or without concomitant chemotherapy for locoregional recurrences after surgery for esophageal cancer is safe and effective. Modern radiotherapy techniques may improve outcomes and reduce treatment-related morbidity.
Collapse
Affiliation(s)
- N Mummudi
- Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - S Jiwnani
- Department of Thoracic Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - D Niyogi
- Department of Thoracic Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - S Srinivasan
- Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - S Ghosh-Laskar
- Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - A Tibdewal
- Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - P Rane
- Department of Bio-statistics, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - G Karimundackal
- Department of Thoracic Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - C S Pramesh
- Department of Thoracic Surgery, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| | - J P Agarwal
- Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
| |
Collapse
|
27
|
Watts GF, Sullivan DR, Hare DL, Kostner KM, Horton AE, Bell DA, Brett T, Trent RJ, Poplawski NK, Martin AC, Srinivasan S, Justo RN, Chow CK, Pang J. Corrigendum to Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: An Australian perspective [American Journal of Preventive Cardiology 6 (2021) 100151]. Am J Prev Cardiol 2022; 9:100200. [DOI: 10.1016/j.ajpc.2021.100200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
28
|
Srinivasan S, Aggarwal N, Makhaik S, Jhobta A, Kapila S, Bhoil R. Role of lung ultrasound in diagnosing and differentiating transient tachypnea of the newborn and respiratory distress syndrome in preterm neonates. J Ultrason 2022; 22:e1-e5. [PMID: 35449705 PMCID: PMC9009341 DOI: 10.15557/jou.2022.0001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Accepted: 12/16/2021] [Indexed: 12/30/2022] Open
Abstract
Aim To evaluate the accuracy of lung ultrasound in diagnosing and differentiating transient tachypnea of the newborn and respiratory distress syndrome in preterm neonates. Material and methods This was a single-center study. From January 2020 to June 2021. A total of 100 preterm neonates, admitted to the neonatal intensive care unit with symptoms of respiratory distress within six hours of birth, including 50 diagnosed with transient tachypnea of the newborn and 50 with respiratory distress syndrome on the basis of clinical examination, laboratory testing, chest X-rays, were recruited in the study. Lung ultrasound was performed in each neonate by a senior radiologist who was blinded to the clinical diagnosis. Lung ultrasound findings in both conditions were analyzed and compared. Results Pulmonary edema manifesting as alveolar-interstitial syndrome, double lung point sign and less commonly as white out lungs in the absence of consolidation has 100% sensitivity and specificity in diagnosing transient tachypnea of the newborn. A combination of three signs of consolidation with air or fluid bronchograms, white out lungs and absent spared areas has 100% sensitivity and specificity for diagnosing respiratory distress syndrome. Double lung point sign was seen only in infants suffering from transient tachypnea of the newborn and consolidation with air or fluid bronchograms only in cases of respiratory distress syndrome. Conclusion Lung ultrasound can accurately diagnose and reliably differentiate transient tachypnea of the newborn and respiratory distress syndrome in preterm neonates. It has advantages that cannot be replicated by chest radiography. Lung ultrasound may be used as an initial screening tool.
Collapse
Affiliation(s)
- S Srinivasan
- Department of Radiology, Indira Gandhi Medical College (IGMC), Shimla, Himachal Pradesh, India
| | - Neeti Aggarwal
- Department of Radiology, Indira Gandhi Medical College (IGMC), Shimla, Himachal Pradesh, India
| | - Sushma Makhaik
- Department of Radiology, Indira Gandhi Medical College (IGMC), Shimla, Himachal Pradesh, India
| | - Anupam Jhobta
- Department of Radiology, Indira Gandhi Medical College (IGMC), Shimla, Himachal Pradesh, India
| | - Sumala Kapila
- Department of Radiology, Indira Gandhi Medical College (IGMC), Shimla, Himachal Pradesh, India
| | - Rohit Bhoil
- Department of Radiology, Indira Gandhi Medical College (IGMC), Shimla, Himachal Pradesh, India
| |
Collapse
|
29
|
Saravanan A, Kumar PS, Srinivasan S, Jeevanantham S, Kamalesh R, Karishma S. Sustainable strategy on microbial fuel cell to treat the wastewater for the production of green energy. Chemosphere 2022; 290:133295. [PMID: 34914952 DOI: 10.1016/j.chemosphere.2021.133295] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Revised: 12/07/2021] [Accepted: 12/11/2021] [Indexed: 06/14/2023]
Abstract
Microbial fuel cell (MFC) is one of the promising alternative energy systems where the catalytic conversion of chemical energy into electrical energy takes places with the help of microorganisms. The basic configuration of MFC consists of three major components such as electrodes (anode and cathode), catalyst (microorganism) and proton transport/exchange membrane (PEM). MFC classified into four types based on the substrate utilized for the catalytic energy conversion process such as Liquid-phase MFC, Solid-phase MFC, Plant-MFC and Algae-MFC. The core performance of MFC is organic substrate oxidation and electron transfer. Microorganisms and electrodes are the key factors that decide the efficiency of MFC system for electricity generation. Microorganism catalysis degradation of organic matters and assist the electron transfer to anode surface, the conductivity of anode material decides the rate of electron transport to cathode through external circuit where electrons are reduced with hydrogen and form water with oxygen. Not limited to electricity generation, MFC also has diverse applications in different sectors including wastewater treatment, biofuel (biohydrogen) production and used as biosensor for detection of biological oxygen demand (BOD) of wastewater and different contaminants concentration in water. This review explains different types of MFC systems and their core performance towards energy conversion and waste management. Also provides an insight on different factors that significantly affect the MFC performance and different aspects of application of MFC systems in various sectors. The challenges of MFC system design, operations and implementation in pilot scale level and the direction for future research are also described in the present review.
Collapse
Affiliation(s)
- A Saravanan
- Department of Energy and Environmental Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - P Senthil Kumar
- Department of Chemical Engineering, Sri Sivasubramaniya Nadar College of Engineering, Chennai, 603110, India; Centre of Excellence in Water Research (CEWAR), Sri Sivasubramaniya Nadar College of Engineering, Chennai, 603110, India.
| | - S Srinivasan
- Department of Biomedical Engineering, Saveetha School of Engineering, SIMATS, Chennai, 602105, India
| | - S Jeevanantham
- Department of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamilnadu, 602105, India
| | - R Kamalesh
- Department of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamilnadu, 602105, India
| | - S Karishma
- Department of Biotechnology, Rajalakshmi Engineering College, Chennai, Tamilnadu, 602105, India
| |
Collapse
|
30
|
Srinivasan S, Duperrex PA, Meer D, Schippers J, Baricevic B, Bisiach D, Cargnelutti M, Oblak M, Paglovec P, Roskar K, Skabar M, Znidarcic M. FLASH in the Clinic Track (Oral Presentations) TOWARDS A REAL-TIME TURN-KEY NON-INTERCEPTIVE, NON-SATURATING, BEAM-SIZE-INDEPENDENT FLASH DIAGNOSTICS SYSTEM AT PSI. Phys Med 2022. [DOI: 10.1016/s1120-1797(22)01551-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
31
|
Saar M, Fizazi K, Shore N, Smith M, Damber JE, Semenov A, Ribal Caparrós M, Birtle A, Rigaud J, Ortiz J, Schmall A, Srinivasan S, Verholen F. Effects of prior local therapy by radical prostatectomy or radiotherapy on the efficacy and safety of darolutamide in patients with nonmetastatic castration-resistant prostate cancer from aramis. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01045-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
32
|
|
33
|
Srinivasan S, Vivek C, Sakthivel P, Chamundeeswari G, Prasanna Bharathi S, Amuthameena S, Balraj B. Synthesis of Ag incorporated ZrO2 nanomaterials for enhanced electrochemical energy storage applications. INORG CHEM COMMUN 2022. [DOI: 10.1016/j.inoche.2022.109262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Khemani P, Srinivasan S, Salunke G, Moulik N, Dhamne C, Chichra A, Gollamudi V, Parambil B, Prasad M, Chinnasamy G, Narula G, Banavali S. Candidemia in pediatric cancer patients contributes to significant morbidity and mortality: A single centre experience from India. Pediatric Hematology Oncology Journal 2022. [DOI: 10.1016/j.phoj.2022.10.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
35
|
Sood S, Srinivasan S. Retrieving embolized peripherally inserted central catheter - A novel two step technique. Radiol Case Rep 2021; 17:531-536. [PMID: 34976259 PMCID: PMC8688964 DOI: 10.1016/j.radcr.2021.11.044] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2021] [Revised: 11/16/2021] [Accepted: 11/16/2021] [Indexed: 11/27/2022] Open
Abstract
We report a novel two-step percutaneous endovascular technique for retrieval of peripherally inserted central catheter, free ends of which were inaccessible, that had embolized to the segmental branch of left pulmonary artery using SIM 1 catheter and a loop snare, in a 17 year old female patient diagnosed with osteosarcoma right femur. Step one involved, inserting SIM 1 catheter through the heart to hook the embolized peripherally inserted central catheter and bring it down to the lower segment of inferior vena cava. In the second step, a loop snare was used to grasp the free end of peripherally inserted central catheter, and the whole assembly was withdrawn via right common femoral vein access. Patient was monitored for 24 hours and discharged as there were no complications. SIM 1 catheter followed by the use of loop snare as a retrieval system is safe and efficacious and can be considered by an intervention radiologist for retrieval of embolized vascular access device, in which none of the free ends are available to catch hold with a loop snare.
Collapse
|
36
|
Dhanjayan R, Suresh S, Srinivasan S, Sahaya Jude Dhas S. Growth Aspects and Optical, Mechanical and Electrical Property Investigation on L-Histidinium-4-Nitrophenolate 4-Nitrophenol (LHPNP) Single Crystal. Polycycl Aromat Compd 2021. [DOI: 10.1080/10406638.2021.2012211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- R. Dhanjayan
- Department of Physics, R&D Centre, Bharathiar University, Coimbatore, India
- Department of Physics, Shree Chandraprabhu Jain College, Minjur, Tamil Nadu, India
| | - S. Suresh
- Department of Physics, Saveetha Engineering College (Autonomous), Thandalam, Chennai, Tamil Nadu, India
| | - S. Srinivasan
- Department of Physics, Presidency College, Chennai, Tamil Nadu, India
| | - S. Sahaya Jude Dhas
- Department of Physics, Kings Engineering College, Sriperumbudur, Chennai, Tamilnadu, India
| |
Collapse
|
37
|
Guilliams KP, Gupta N, Srinivasan S, Binkley MM, Ying C, Couture L, Gross J, Wallace A, McKinstry RC, Vo K, Lee JM, An H, Goyal MS. MR Imaging Differences in the Circle of Willis between Healthy Children and Adults. AJNR Am J Neuroradiol 2021; 42:2062-2069. [PMID: 34556478 PMCID: PMC8583273 DOI: 10.3174/ajnr.a7290] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Accepted: 07/19/2021] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Asymmetries in the circle of Willis have been associated with several conditions, including migraines and stroke, but they may also be age-dependent. This study examined the impact of age and age-dependent changes in cerebral perfusion on circle of Willis anatomy in healthy children and adults. MATERIALS AND METHODS We performed an observational, cross-sectional study of bright and black-blood imaging of the proximal cerebral vasculature using TOF-MRA and T2 sampling perfection with application-optimized contrasts by using different flip angle evolution (T2-SPACE) imaging at the level of the circle of Willis in 23 healthy children and 43 healthy adults (4-74 years of age). We compared arterial diameters measured manually and cerebral perfusion via pseudocontinuous arterial spin-labeling between children and adults. RESULTS We found that the summed cross-sectional area of the circle of Willis is larger in children than in adults, though the effect size was smaller with T2-SPACE-based measurements than with TOF-MRA. The circle of Willis is also more symmetric in children, and nonvisualized segments occur more frequently in adults than in children. Moreover, the size and symmetry of the circle of Willis correlate with cerebral perfusion. CONCLUSIONS Our results demonstrate that the circle of Willis is different in size and symmetry in healthy children compared with adults, likely associated with developmental changes in cerebral perfusion. Further work is needed to understand why asymmetric vasculature develops in some but not all adults.
Collapse
Affiliation(s)
- K P Guilliams
- From the Department of Neurology (K.P.G., M.M.B., J.-M.L., M.S.G.)
- Department of Pediatrics (K.P.G., R.C.M.)
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - N Gupta
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - S Srinivasan
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - M M Binkley
- From the Department of Neurology (K.P.G., M.M.B., J.-M.L., M.S.G.)
| | - C Ying
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - L Couture
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - J Gross
- Division of Neuroradiology (J.G.), Midwest Radiology, St. Paul, Minnesota
| | - A Wallace
- Department of Neurointerventional Surgery (A.W.), Ascension Columbia St. Mary's Hospital, Milwaukee, Wisconsin
| | - R C McKinstry
- Department of Pediatrics (K.P.G., R.C.M.)
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - K Vo
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - J-M Lee
- From the Department of Neurology (K.P.G., M.M.B., J.-M.L., M.S.G.)
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
- Department of Biomedical Engineering (J.-M.L.)
| | - H An
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
| | - M S Goyal
- From the Department of Neurology (K.P.G., M.M.B., J.-M.L., M.S.G.)
- Mallinckrodt Institute of Radiology (K.P.G., N.G., S.S., C.Y., L.C., R.C.M., K.V., J.-M.L., H.A., M.S.G.)
- Neuroscience (M.S.G.), Washington University School of Medicine, St. Louis, Missouri
| |
Collapse
|
38
|
Cacho F, Srinivasan S, Schoumacher R, Hamilton R, Ledbetter J, Moser M, Callison J, Mathes R, Quintero D, Metcalf A, Eastman S, Tolle J, Rushing S, Brown R. 346: Tennessee cystic fibrosis clinical care during the COVID-19 pandemic. J Cyst Fibros 2021. [PMCID: PMC8518430 DOI: 10.1016/s1569-1993(21)01770-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Kandala A, Wei KX, Srinivasan S, Magesan E, Carnevale S, Keefe GA, Klaus D, Dial O, McKay DC. Demonstration of a High-Fidelity cnot Gate for Fixed-Frequency Transmons with Engineered ZZ Suppression. Phys Rev Lett 2021; 127:130501. [PMID: 34623861 DOI: 10.1103/physrevlett.127.130501] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/11/2020] [Accepted: 07/28/2021] [Indexed: 06/13/2023]
Abstract
Improving two-qubit gate performance and suppressing cross talk are major, but often competing, challenges to achieving scalable quantum computation. In particular, increasing the coupling to realize faster gates has been intrinsically linked to enhanced cross talk due to unwanted two-qubit terms in the Hamiltonian. Here, we demonstrate a novel coupling architecture for transmon qubits that circumvents the standard relationship between desired and undesired interaction rates. Using two fixed frequency coupling elements to tune the dressed level spacings, we demonstrate an intrinsic suppression of the static ZZ while maintaining large effective coupling rates. Our architecture reveals no observable degradation of qubit coherence (T_{1},T_{2}>100 μs) and, over a factor of 6 improvement in the ratio of desired to undesired coupling. Using the cross-resonance interaction, we demonstrate a 180 ns single-pulse controlled not (cnot) gate, and measure a cnot fidelity of 99.77(2)% from interleaved randomized benchmarking.
Collapse
Affiliation(s)
- A Kandala
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - K X Wei
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - S Srinivasan
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - E Magesan
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - S Carnevale
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - G A Keefe
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - D Klaus
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - O Dial
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| | - D C McKay
- IBM Quantum, IBM T.J. Watson Research Center, Yorktown Heights, New York 10598, USA
| |
Collapse
|
40
|
Kombathula S, Pareek P, Srinivasan S, Kannikanti D, Solanki A, Vyas R, Kamal M, Vishnoi J, Bhardwaj P, Misra S. 1454P A prospective trial evaluating the impact of tele-palliative care in cancer patients: Exploring opportunities in adversities. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
41
|
Srinivasan S, Yee N, Mahmoodi A, Zakharian M, Saville M, Oneto JM. 9P Click Activated Protodrugs Against Cancer (CAPAC) platform enhances the safety, pharmacokinetics, and antitumor efficacy of cancer therapies in vivo. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
42
|
Subbiah V, Bhadri V, Bui N, Batty K, Strach M, Zakharian M, Smith S, Yee N, Srinivasan S, Saville M, Mejía Oneto J, Guminski A. 547P Early pharmacokinetic data from a phase I study of SQ3370 in patients with advanced solid tumors provides proof-of-concept for the click chemistry-based CAPAC platform. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
43
|
Vora KA, Hanna CA, Neville KA, Bergman PB, Grover SR, O'Connell MA, Srinivasan S. Role of cross-campus multidisciplinary team meetings in decision-making for children and adolescents with differences of sex development/intersex. J Paediatr Child Health 2021; 57:1402-1407. [PMID: 33928709 DOI: 10.1111/jpc.15474] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 12/21/2020] [Accepted: 03/26/2021] [Indexed: 11/29/2022]
Abstract
AIM Management of children with differences/disorders of sex development (DSD) is complex with limited evidence to guide clinical decisions. Regular multidisciplinary team meetings were set up in Sydney and Melbourne paediatric hospitals to enable systematic peer review of complex decision-making. We aim to describe the workload and role of these meetings. METHODS The multidisciplinary team forum includes invited representatives from endocrinology, urology, gynaecology, genetics, psychology, social work, clinical ethics, laboratory and hospital executive and meetings occur 1-3 times monthly. Descriptive data were collected from de-identified meeting referrals and minutes between August 2012 to August 2018 (Sydney) and January 2014 to August 2018 (Melbourne). RESULTS A total of 192 referrals (142 new and 50 follow-ups) aged 1 week to 17 years were discussed across the two sites. 46, XY DSD (n = 81) was the most common sub-classification. Consideration of surgical options and optimal management of gonads with malignant potential were amongst the common reasons for referral to the multidisciplinary team meetings. Surgical interventions were considered but not recommended after review for 38 of 154 (24.7%) procedures. Gonad retention to allow potential functional benefit was recommended in 15/46 (32.6%) referrals. Evidence of premalignant or malignant changes was found in 20/57 (35%) gonads removed, with dysgenetic features and atrophy/streak features in 6 (10.5%) and 27 (47.4%) gonads respectively. CONCLUSION Formal DSD multidisciplinary team meetings provide a framework and opportunity for multi and interdisciplinary discussions amongst representatives from several specialities to help make complex decision-making.
Collapse
Affiliation(s)
- Komal A Vora
- Department of Paediatric Endocrinology, John Hunter Children's Hospital, Newcastle, NSW, Australia.,School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.,Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, NSW, Australia
| | - Chloe A Hanna
- Department of Gynaecology, The Royal Children's Hospital, Melbourne, Victoria, Australia.,Reproductive development, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.,Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
| | - Kristen A Neville
- Department of Endocrinology, Sydney Children's Hospital, Sydney, NSW, Australia.,School of Women and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia
| | - Philip B Bergman
- Department of Paediatric Endocrinology & Diabetes, Monash Children's Hospital, Melbourne, Victoria, Australia.,Department of Paediatrics, Monash University, Melbourne, Victoria, Australia
| | - Sonia R Grover
- Department of Gynaecology, The Royal Children's Hospital, Melbourne, Victoria, Australia.,Reproductive development, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.,Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
| | - Michele A O'Connell
- Reproductive development, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.,Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.,Department of Endocrinology and Diabetes, The Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Shubha Srinivasan
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, NSW, Australia.,Children's Hospital Westmead Clinical School, University of Sydney, Sydney, NSW, Australia
| |
Collapse
|
44
|
Srivastava R, Mohan R, Saravana Balaji MD, Vijay VK, Srinivasan S, Navarasu M. A Randomized Controlled Trial on a Minimally Invasive Microsurgical Versus Conventional Procedure for the Management of Localized Gingival Recession in Esthetic Zone using Alloderm. J Pharm Bioallied Sci 2021; 13:S476-S483. [PMID: 34447138 PMCID: PMC8375812 DOI: 10.4103/jpbs.jpbs_756_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2020] [Revised: 11/22/2020] [Accepted: 11/23/2020] [Indexed: 11/24/2022] Open
Abstract
Background: Microsurgical technique is a recent advancement in periodontal plastic surgery, which improves the predictability of periodontal procedures, providing better esthetic results with minimal postoperative discomfort. Alloderm is an alternate to connective tissue grafts, which has been successfully used for root coverage. The present study aims at Comparative assessment of Micro and Conventional surgical techniques for root coverage using coronally positioned flap (CPF) with Alloderm. Materials and Methods: Twenty sites with Miller's Class I or II gingival recession defects were selected; sites were randomly divided into control and test groups. Test sites were treated with CPF and acellular dermal matrix (ADM) using Microsurgery and control sites were treated with CPF and ADM using conventional method. Results: Conventional and Microsurgical procedures for root coverage showed a statistically significant difference in all clinical parameters from baseline to 3 and 6 months (P < 0.01). The microsurgical technique demonstrated a significant difference in ultrasonographic thickness of gingiva (P < 0.003) and patient satisfaction score (P < 0.005). Conclusion: Microsurgical procedure for root coverage was found to be superior to the conventional macrosurgical approach under magnification. Microsurgical sites healed faster with neovascularization demonstrated on ultrasonographic evaluation with improved gingival thickness and patient satisfaction scores.
Collapse
Affiliation(s)
- Robin Srivastava
- Consulting Periodontist, Savitri Hospital, Jhansi, Uttar Pradesh, India
| | - Ranjana Mohan
- Department of Periodontology, RVS Dental College and Hospital, Coimbatore, Tamil Nadu, India
| | - M D Saravana Balaji
- Department of Periodontology, RVS Dental College and Hospital, Coimbatore, Tamil Nadu, India
| | - V K Vijay
- Department of Periodontology, Best Dental College and Hospital, Madurai, Tamil Nadu, India
| | - S Srinivasan
- Department of Periodontology, Rajah Muthaiah Dental College and Hospital, Chidambaram, Tamil Nadu, India
| | - M Navarasu
- Department of Periodontics, Best Dental College and Hospital, Madurai, Tamil Nadu, India
| |
Collapse
|
45
|
Yeung J, Chisholm K, Spinks C, Srinivasan S. Familial hypercholesterolaemia: Experience of a tertiary paediatric lipid clinic. J Paediatr Child Health 2021; 57:1201-1207. [PMID: 33830584 DOI: 10.1111/jpc.15426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/29/2020] [Revised: 01/02/2021] [Accepted: 02/14/2021] [Indexed: 11/28/2022]
Abstract
AIM To review the experience of a dedicated paediatric multidisciplinary lipid clinic in the management of familial hypercholesterolaemia (FH) by studying the demographics, clinical presentations as well as statin therapy and outcomes. METHODS Retrospective database review of all patients under 18 years old seen in the lipid clinic at an Australian tertiary paediatric hospital between April 1999 and August 2017. Outcome measures collected included patient demographics, family history, lipid profile, age at treatment commencement, treatment outcomes and complications. RESULTS One hundred and eight patients (53 males) were seen in the lipid clinic. Eighty-five had low-density lipoprotein cholesterol (LDL-C) levels at or above the 75th percentile for sex prior to treatment. Of these, 75 had a first-degree relative with hypercholesterolaemia and/or early cardiac death. Four patients had clinical manifestations. Thirty-two patients (14 males) were started on statin therapy for likely FH. LDL-C levels reduced by 2.4 mmol/L (1.4 to 2.7) in boys and 1.9 mmol/L (0.8 to 2.8) in girls at 12 month follow-up. Five patients reported side effects requiring adjustment in therapy. Main reasons for not starting statin therapy in eligible patients were parental refusal and/or lost to follow up (77%). CONCLUSION A dedicated multidisciplinary lipid clinic is helpful for streamlining and monitoring management of paediatric FH. Clinical manifestations of FH are rare in children and may represent more severe form of FH or other lipid disorder. Statin therapy is efficacious and well tolerated but current recommended targets of treatment are difficult to attain. Greater awareness and coordinated services are required to overcome poor family engagement.
Collapse
Affiliation(s)
- Jeffrey Yeung
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
| | - Kerryn Chisholm
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
| | - Catherine Spinks
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.,Clinical Genetics Unit. Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
| | - Shubha Srinivasan
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
| |
Collapse
|
46
|
Bindra S, Singh I, Gill BS, Grewal SK, Kaur J, Kaur L, Salaria S, Kaur A, Kushwah A, Srinivasan S, Singh S. Inheritance and biochemical basis of yellowing of apical leaves: a unique trait in chickpea (Cicer arietinum L.). J Genet 2021. [DOI: 10.1007/s12041-021-01302-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
47
|
Watts GF, Sullivan DR, Hare DL, Kostner KM, Horton AE, Bell DA, Brett T, Trent RJ, Poplawski NK, Martin AC, Srinivasan S, Justo RN, Chow CK, Pang J. Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians. Intern Med J 2021; 51:769-779. [PMID: 34047032 DOI: 10.1111/imj.15327] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Revised: 03/05/2021] [Accepted: 03/16/2021] [Indexed: 11/28/2022]
Abstract
Familial hypercholesterolaemia (FH) is a common, heritable and preventable cause of premature coronary artery disease. New clinical practice recommendations are presented to assist practitioners in enhancing the care of all patients with FH. Core recommendations are made on the detection, diagnosis, assessment and management of adults, children and adolescents with FH. Management is under-pinned by the precepts of risk stratification, adherence to healthy lifestyles, treatment of non-cholesterol risk factors and appropriate use of low-density lipoprotein (LDL)-cholesterol-lowering therapies including statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. The recommendations need to be utilised using judicious clinical judgement and shared decision-making with patients and families. New government-funded schemes for genetic testing and use of PCSK9 inhibitors, as well as the National Health Genomics Policy Framework, will enable adoption of the recommendations. However, a comprehensive implementation science and practice strategy is required to ensure that the guidance translates into benefit for all families with FH.
Collapse
Affiliation(s)
- Gerald F Watts
- School of Medicine, University of Western Australia, Perth, Western Australia, Australia.,Lipid Disorders Clinic, Cardiometabolic Service, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia
| | - David R Sullivan
- Department of Chemical Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.,Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
| | - David L Hare
- Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.,Department of Cardiology, Austin Health, Melbourne, Victoria, Australia
| | - Karam M Kostner
- Department of Cardiology, Mater Hospital, University of Queensland, Brisbane, Queensland, Australia
| | - Ari E Horton
- Monash Heart and Monash Children's Hospital, Monash Health, Melbourne, Victoria, Australia.,Monash Cardiovascular Research Centre, Melbourne, Victoria, Australia.,Department of Paediatrics, Monash University, Melbourne, Victoria, Australia
| | - Damon A Bell
- School of Medicine, University of Western Australia, Perth, Western Australia, Australia.,Lipid Disorders Clinic, Cardiometabolic Service, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia.,Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital and Fiona Stanley Hospital Network, Perth, Western Australia, Australia.,Department of Clinical Biochemistry, Clinipath Pathology, Perth, Western Australia, Australia.,Sonic Genetics, Sonic Pathology, Sydney, New South Wales, Australia
| | - Tom Brett
- General Practice and Primary Health Care Research, School of Medicine, University of Notre Dame Australia, Perth, Western Australia, Australia
| | - Ronald J Trent
- Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.,Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
| | - Nicola K Poplawski
- Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.,Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia
| | - Andrew C Martin
- Department General Paediatrics, Perth Children's Hospital, Perth, Western Australia, Australia.,Division of Paediatrics, University of Western Australia, Perth, Western Australia, Australia
| | - Shubha Srinivasan
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.,Discipline of Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
| | - Robert N Justo
- Department of Paediatric Cardiology, Queensland Children's Hospital, Brisbane, Queensland, Australia.,School of Medicine, University of Queensland, Brisbane, Queensland, Australia
| | - Clara K Chow
- Westmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia.,Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia.,George Institute for Global Health, Sydney, New South Wales, Australia
| | - Jing Pang
- School of Medicine, University of Western Australia, Perth, Western Australia, Australia
| | | |
Collapse
|
48
|
Vickram A, Srikumar P, Srinivasan S, Jeyanthi P, Anbarasu K, Thanigaivel S, Nibedita D, Jenila Rani D, Rohini K. Seminal exosomes - An important biological marker for various disorders and syndrome in human reproduction. Saudi J Biol Sci 2021; 28:3607-3615. [PMID: 34121904 PMCID: PMC8176048 DOI: 10.1016/j.sjbs.2021.03.038] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2020] [Revised: 03/09/2021] [Accepted: 03/09/2021] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND Exosomes are nano-sized membrane vesicles, secreted by different types of cells into the body's biological fluids. They are found in abundance in semen as compared to other fluids. Exosomes contain a cargo of lipid molecules, proteins, phospholipids, cholesterol, mRNAs, and miRNAs. Each molecule of seminal exosomes (SE) has a potential role in male reproduction for childbirth. Many potential candidates are available within the seminal exosomes that can be used as diagnostic markers for various diseases or syndromes associated with male reproduction. Also these seminal exospmes play a major role in female reproductive tract for effective fertilization. AIM The aim of this review is to focus on the advancement of human seminal exosomal research and its various properties. METHODS We used many databases like Scopus, Google scholar, NCBI-NLM and other sources to filter the articles of interest published in exosomes. We used phrases like "Exosomes in human semen", "Composition of exosomes in human semen" and other relevant words to filter the best articles. RESULTS Seminal exosomes play a major role in sperm functions like cell-to-cell communication, motility of the sperm cells, maintaining survival capacity for the sperm in the female reproductive tract and spermatogenesis. Also, seminal exosomes are used as a carrier for many regulatory elements using small RNA molecules. miRNAs of the seminal exosomes can be used as a diagnostic marker for prostate cancer instead of prostate specific antigen (PSA). Epididymosomes can be used as a biomarker for reproductive diseases and male infertility. CONCLUSION Seminal exosomes could be used as biological markers for various reproductive disorders, male infertility diagnosis, and it can be used in anti-retroviral research for the identification of novel therapeutics for HIV-1 infection and transmission.
Collapse
Affiliation(s)
- A.S. Vickram
- Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| | - P.S. Srikumar
- Unit of Psychiatry, Faculty of Medicine, AIMST University, Semeling, Bedong, Kedah,Malaysia
| | - S. Srinivasan
- Department of Biomedical Engineering, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| | - Palanivelu Jeyanthi
- Department of Biotechnology, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Chennai, Tamil Nadu, India
| | - K. Anbarasu
- Department of Bioinformatics, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| | - S. Thanigaivel
- Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| | - Dey Nibedita
- Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| | - D. Jenila Rani
- Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India
| | - Karunakaran Rohini
- Unit of Biochemistry, Faculty of Medicine, AIMST University, Semeling, Bedong, Kedah, Malaysia
| |
Collapse
|
49
|
Graves LE, Stewart K, Ambler GR, Bhattacharya K, Srinivasan S. Investigating paediatric hypoglycaemia: Dynamic studies at a tertiary paediatric hospital. J Paediatr Child Health 2021; 57:888-893. [PMID: 33428304 DOI: 10.1111/jpc.15349] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Revised: 10/24/2020] [Accepted: 12/28/2020] [Indexed: 12/31/2022]
Abstract
AIM Paediatric hypoglycaemia often requires specific investigations to determine aetiology. Samples from the time of hypoglycaemia may not be available and a diagnostic fasting test may be required. Additionally, fasting studies can determine safe fasting intervals and prolonged oral glucose challenges can assess hypoglycaemia due to abnormal post-prandial glucose handling. This audit reviewed the current utility and yield of fasting studies, prolonged oral glucose challenges and starch loads. METHODS Retrospective audit of clinical record to determine purpose and outcome of tests performed at a Tertiary Paediatric Endocrine/Metabolic Testing Unit in Sydney, Australia, from 2013 to 2018 inclusive. RESULTS One hundred and thirty-eight children (aged 3 weeks-17 years) underwent 170 tests: 122 fasting studies, 20 five-hour OGTTs, 22 uncooked corn starch loads and six modified waxy maize starch (Glycosade) loads. The majority were for diagnostic purposes (n = 113, 66%), with 57 (34%) to guide management in patients with known diagnoses. Following diagnostic studies, 35 (31%) patients received a pathological diagnosis, the most common of which (n = 19, 17%) was accelerated starvation. Hypoglycaemia developed in n = 15/113 (13%) during the diagnostic studies. Management studies helped determine length of safe fast, adjustment of medication or diet and document resolution of pathology. CONCLUSION Fasting studies remain a safe and effective method to assist with diagnoses, confirm or exclude pathological causes of childhood hypoglycaemia and to guide management of known diagnoses in the paediatric population.
Collapse
Affiliation(s)
- Lara E Graves
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
| | - Kelly Stewart
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
| | - Geoffrey R Ambler
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.,Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
| | - Kaustuv Bhattacharya
- Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia.,Department of Genetic Metabolic Disorders, the Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, New South Wales, Australia
| | - Shubha Srinivasan
- Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.,Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
| |
Collapse
|
50
|
Feyerabend S, Shore N, Smith M, Kopyltsov E, Antonyan I, Damber J, Gasparro D, Yildirim A, Hellstrom M, Vjaters E, Ortiz J, Srinivasan S, Sarapohja T, Fizazi K. Clinical benefit and safety profile of darolutamide in patients who crossed over to darolutamide from placebo during the open-label period of the phase 3 ARAMIS study. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01598-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|